Skip to main content
. Author manuscript; available in PMC: 2013 Mar 27.
Published in final edited form as: Transplantation. 2012 Mar 27;93(6):603–609. doi: 10.1097/TP.0b013e318245b2af

FIGURE 2. (A) Patient Survival and (B) Graft Loss After LDKT, Comparing ABO Incompatible Recipients (Dashed Line) with ABO Compatible Matched Controls (Solid Line).

FIGURE 2

FIGURE 2

ABOc controls were matched to ABOi recipients on presence of diabetes, crossmatch status, recipient age, year of transplant, recipient insurance type, peak percent panel reactive antigen, and years of renal replacement therapy.